This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): SAR7226
Description: SAR7226 is an SGLT1/2 inhibitor. The sodium-glucose co-transporter SGLT is found in the intestines and in the kidney. SGLT1 is responsible for uptake of glucose in the intestines, and SGLT2 is responsible for most of the re-absorption of glucose that has been excreted in the urine.
Additional information available to subscribers only: